Trial
NCT05407389
Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Kibow Pharma
Collaborators
—
Condition
Chronic Kidney Disease stage4
Intervention
KT-301 (formerly US-APR2020)
Why stopped
Logistics, company reorganization.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19